Courage Therapeutics is a research organization that develops new medicines for eating disorders.
Courage Therapeutics has raised $7.8M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Courage Therapeutics's investors include What If Ventures, Arsenal Bridge Ventures, Michigan Biomedical Venture Fund.
Courage Therapeutics is headquartered in Newton, United States.
Courage Therapeutics is a research organization that develops new medicines for eating disorders.
Courage Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Courage Therapeutics — Funding & Investors." VCBacked, May 16, 2025, https://www.vcbacked.co/company/courage-therapeutics. Accessed August 1, 2026.
VCBacked. (2025). Courage Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/courage-therapeutics
{{cite web |title=Courage Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/courage-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated